A Marie Skłodowska-Curie (MCSA) postdoctoral position at the MAX IV synchrotron radiation facility, Lund, Sweden.
Development of microfluidics on the CoSAXS beamline at MAX IV.
Small-angle X-ray scattering (SAXS) combined with microfluidics has emerged as a powerful tool for studying biomolecular interactions, nanoparticle assembly, and other structural changes in real time. Microfluidic devices enable precise control over rapid mixing, optimised sample consumption, dilution, and nanoscale monitoring of molecular interactions, e.g. for protein folding studies, drug screening, and soft matter research.
The main task is to conduct research and develop independence as a researcher. The position includes the opportunity for further training and courses in consultation with the PI. You will focus on the development of online microfluidic technology. The development will be driven by biomedical (protein aggregation & amyloid systems, lipid nanoparticle assembly), soft matter and industrial (polymer synthesis, emulsions, hydrogels, self assembly) applications. The successful applicant will be a highly motivated individual with a strong academic background in the physical sciences and will be expected to work closely with both beamline scientists and scientists from the user community whose projects require this unique technological combination.
Techniques involved will include X-ray small-angle scattering (SAXS), and possibly cryo-EM. The successful applicant will have good access to advanced international facility centres for synchrotron X-ray and neutron beams such as MAX IV, and possibly during the course of this project, ESS.
The project is resourced through the MCSA AMBER project – for further details and application instructions, see https://www.ambercofund.eu/. Applicants are strongly encouraged to contact the PI for the project, Dr. Ann Terry (ann.terry@maxiv.lu.se) before applying.
Deadline: 28th September 2025.
